B-CELL LYMPHOMA A051701
Study #A051701Randomized Phase II/III Study of Ventoclax (ABT 199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double-Expressing Lymphomas
Back To Clinical Trials NCI Database Entry
Randomized Phase II/III Study of Ventoclax (ABT 199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double-Expressing Lymphomas
Back To Clinical Trials NCI Database Entry